online tender for rate contract for procurement of second line anti tb drugs - moxifloxacin-400mg, clofazimine-100mg, cycloserine-250mg, delamanid-50mg, ethambutol-400mg, ethambutol-800mg, levofloxacin-250mg, levofloxacin-500mg, pyrazinamide-500mg, pyrazinamide-750mg, rifampicin-150mg, rifampicin-300mg, rifampicin-450mg, moxifloxacin-400mg (developmental tender schedule), clofazimine-100mg (developmental tender schedule), delamanid-50mg (developmental tender schedule), ethambutol-400mg (develop

Central Medical Services Society has invited bids for the online tender for rate contract for procurement of second line anti tb drugs - moxifloxacin-400mg, clofazimine-100mg, cycloserine-250mg, delamanid-50mg, ethambutol-400mg, ethambutol-800mg, levofloxacin-250mg, levofloxacin-500mg, pyrazinamide-500mg, pyrazinamide-750mg, rifampicin-150mg, rifampicin-300mg, rifampicin-450mg, moxifloxacin-400mg (developmental tender schedule), clofazimine-100mg (developmental tender schedule), delamanid-50mg (developmental tender schedule), ethambutol-400mg (developmental tender schedule), rifampicin-150mg (developmental tender schedule), rifampicin-300mg (developmental tender schedule), rifampicin-450mg (developmental tender schedule) for ntep., with an EMD of ₹0 Cr. Please refer to the tender document for project value details. Interested bidders can submit applications until 5 October 2026, with the technical opening scheduled for 6 October 2026.